The N(6)-Methyladenosine-Modified Pseudogene HSPA7 Correlates With the Tumor Microenvironment and Predicts the Response to Immune Checkpoint Therapy in Glioblastoma

BACKGROUND: Glioblastoma (GBM), one of the most aggressive tumors of the brain, has no effective or sufficient therapies. Identifying robust biomarkers for the response to immune checkpoint blockade (ICB) therapy, a promising treatment option for GBM patients, is urgently needed. METHODS: We compreh...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Rongrong, Li, Boyan, Zhang, Shouji, He, Zheng, Pan, Ziwen, Guo, Qindong, Qiu, Wei, Qi, Yanhua, Zhao, Shulin, Wang, Shaobo, Chen, Zihang, Zhang, Ping, Guo, Xing, Xue, Hao, Li, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329659/
https://www.ncbi.nlm.nih.gov/pubmed/34354698
http://dx.doi.org/10.3389/fimmu.2021.653711

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329659/
https://www.ncbi.nlm.nih.gov/pubmed/34354698
http://dx.doi.org/10.3389/fimmu.2021.653711

Ejemplares similares